MCMC
Matrix Capital Management Company Portfolio holdings
AUM
$223M
This Quarter Return
+10.11%
1 Year Return
-12.57%
3 Year Return
+145.82%
5 Year Return
+136.54%
10 Year Return
+717.06%
AUM
$2.15B
AUM Growth
+$2.15B
(+2.7%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-6.41%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
GlobalFoundries
GFS
|
$96.5M |
| 2 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$35.8M |
| 3 |
Adaptive Biotechnologies
ADPT
|
$3.33M |
| 4 |
Perimeter Solutions
PRM
|
$2.19M |
Sector Composition
| 1 | Technology | 91.5% |
| 2 | Healthcare | 4.61% |
| 3 | Materials | 3.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALTR
1
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $1.36B | 63.04% | 12,430,000 | – | – |
|
|
2
GlobalFoundries
GFS
$18.5B
| $612M | 28.45% | 14,264,952 -2,250,000 | -14% | -$96.5M |
|
|
3
Perimeter Solutions
PRM
$3.28B
| $83.8M | 3.89% | 6,554,000 -171,000 | -3% | -$2.19M |
|
4
Aura Biosciences
AURA
$389M
| $56.9M | 2.65% | 6,922,870 | – | – |
|
5
Zentalis Pharmaceuticals
ZNTL
$122M
| $42.3M | 1.97% | 13,959,973 | – | – |
|
|
ADAP
6
Adaptimmune Therapeutics
ADAP
$15.6M
| – | – | -37,681,515 | Closed | -$35.8M |
|
|
7
Adaptive Biotechnologies
ADPT
$2.01B
| – | – | -650,000 | Closed | -$3.33M |
|